Table 4.
Index cases |
Matched controls |
First-degree relatives, LFS cancer at ages 19–55 |
First-degree relatives, non-LFS cancer at ages 19–55 |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Relatives of cases |
Relatives of controls |
Relatives of cases |
Relatives of controls |
|||||||||||
Diagnosed | Undiagnosed | Diagnosed | Undiagnosed | Diagnosed | Undiagnosed | Diagnosed | Undiagnosed | |||||||
Cancer of pediatric case |
N | N | OR (95% CI) |
p | N | OR (95% CI) |
p | |||||||
Any cancer, ages 0–4 | 1,552 | 7,760 | 26 | 2,858 | 63 | 16,053 | 2.2 (1.4–3.5) | <10–3 | 52 | 2,832 | 212 | 15,904 | 1.3 (1.0–1.8) | 0.10 |
Any cancer, ages 0–18 | 4,482 | 22,410 | 75 | 8,778 | 244 | 50,702 | 1.7 (1.3–2.1) | <10–3 | 166 | 8,687 | 711 | 50,235 | 1.3 (1.1–1.5) | <0.01 |
ICCC-3 classification, ages 0–18 | ||||||||||||||
Leukemias, myeloproliferative | 1,150 | 5,750 | 22 | 2,040 | 56 | 12,607 | 2.2 (1.3–3.5) | <10–3 | 35 | 2,027 | 155 | 12,508 | 1.2 (0.9–1.8) | 0.28 |
CNS and intracranial/spinal | 870 | 4,350 | 13 | 1,805 | 37 | 9,796 | 1.8 (1.0–3.5) | 0.06 | 29 | 1,789 | 139 | 9,694 | 1.1 (0.7–1.6) | 0.72 |
Lymphomas, reticuloendothelial | 578 | 2,890 | 9 | 1,076 | 34 | 6,688 | 1.5 (0.7–3.1) | 0.29 | 25 | 1,060 | 105 | 6,617 | 1.4 (0.9–2.1) | 0.17 |
Other epithelial, melanomas | 480 | 2,400 | 11 | 1,002 | 34 | 5,522 | 1.7 (0.9–3.5) | 0.12 | 20 | 993 | 66 | 5,490 | 1.6 (1.0–2.7) | 0.06 |
Soft tissue, other sarcomas | 304 | 1,520 | 6 | 625 | 20 | 3,561 | 1.6 (0.6–3.9) | 0.35 | 8 | 623 | 54 | 3,527 | 0.8 (0.4–1.6) | 0.84 |
Malignant bone tumors | 258 | 1,290 | 8 | 534 | 24 | 3,107 | 1.6 (0.7–3.6) | 0.25 | 16 | 526 | 60 | 3,071 | 1.3 (0.7–2.3) | 0.38 |
Neuroblastoma, nervous cell | 254 | 1,270 | 4 | 432 | 19 | 2,700 | 1.4 (0.5–4.1) | 0.59 | 12 | 424 | 25 | 2,694 | 3.1 (1.5–6.4) | <0.01 |
Germ cell tumors | 262 | 1,310 | 1 | 493 | 16 | 2,890 | 0.4 (0.1–2.7) | 0.31 | 8 | 486 | 47 | 2,859 | 1.0 (0.5–2.1) | 0.94 |
Renal tumors | 203 | 1,015 | 1 | 487 | 17 | 2,410 | 0.2 (0.0–1.8) | 0.17 | 10 | 478 | 36 | 2,391 | 1.2 (0.6–2.4) | 0.64 |
Retinoblastomas | 87 | 435 | 1 | 173 | 7 | 998 | 0.7 (0.1–5.7) | 0.71 | 2 | 172 | 10 | 995 | 1.0 (0.2–4.5) | 0.97 |
Hepatic tumors | 60 | 300 | 0 | 100 | 1 | 560 | Undetermined | – | 3 | 97 | 8 | 553 | 1.8 (0.5–7.1) | 0.39 |
Cases compared to controls matched 5:1 on sex, birth year and birthplace (in Utah or outside of Utah).
Abbreviations: OR: odds ratio from conditional logistic regression; ICCC-3: International Classification of Childhood Cancer, Third edition13; CNS: central nervous system.